13058_2015_625_MOESM6_ESM.doc (37 kB)
Additional file 6: Table S5. of A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
journal contribution
posted on 2015-08-16, 05:00 authored by Anja Rudolph, Peter Fasching, Sabine Behrens, Ursula Eilber, Manjeet Bolla, Qin Wang, Deborah Thompson, Kamila Czene, Judith Brand, Jingmei Li, Christopher Scott, V. Pankratz, Kathleen Brandt, Emily Hallberg, Janet Olson, Adam Lee, Matthias Beckmann, Arif Ekici, Lothar Haeberle, Gertraud Maskarinec, Loic Le Marchand, Fredrick Schumacher, Roger Milne, Julia Knight, Carmel Apicella, Melissa Southey, Miroslav Kapuscinski, John Hopper, Irene Andrulis, Graham Giles, Christopher Haiman, Kay-Tee Khaw, Robert Luben, Per Hall, Paul Pharoah, Fergus Couch, Douglas Easton, Isabel dos-Santos-Silva, Celine Vachon, Jenny Chang-ClaudeBeta estimates for interactions between selected single nucleotide polymorphisms (SNPs) in PLCG2 and current use of menopausal hormone therapy (MHT) on square-root-transformed percent mammographic density in women not diagnosed with breast cancer and in women with breast cancer. Chr chromosome. (DOC 37 kb)
